These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

903 related items for PubMed ID: 15586364

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M, Kerkhof M, Steyerberg EW, Kusters JG, van Strien PM, Looman CW, van Dekken H, Siersema PD, Kuipers EJ.
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
    Krishnadath KK, Tilanus HW, Alers JC, Mulder AH, van Dekken H.
    Cytometry; 1994 Feb 01; 15(2):176-84. PubMed ID: 8168405
    [Abstract] [Full Text] [Related]

  • 5. Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.
    Ortner M-, Zumbusch K, Liebetruth J, Ebert B, Fleige B, Dietel M, Lochs H.
    Endoscopy; 2002 Aug 01; 34(8):611-6. PubMed ID: 12173080
    [Abstract] [Full Text] [Related]

  • 6. Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer.
    Wolfsen HC, Hemminger LL, Wallace MB, Devault KR.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1125-31. PubMed ID: 15569115
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.
    Mod Pathol; 2001 May 15; 14(5):397-403. PubMed ID: 11353048
    [Abstract] [Full Text] [Related]

  • 9. Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus.
    Krishnadath KK, Tilanus HW, van Blankenstein M, Bosman FT, Mulder AH.
    J Pathol; 1995 Feb 15; 175(2):175-80. PubMed ID: 7738712
    [Abstract] [Full Text] [Related]

  • 10. High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice.
    Thomas T, Richards CJ, de Caestecker JS, Robinson RJ.
    Aliment Pharmacol Ther; 2005 Mar 15; 21(6):747-55. PubMed ID: 15771761
    [Abstract] [Full Text] [Related]

  • 11. Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.
    Kelty CJ, Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW.
    Aliment Pharmacol Ther; 2004 Dec 15; 20(11-12):1289-96. PubMed ID: 15606390
    [Abstract] [Full Text] [Related]

  • 12. Prevention of the neoplastic progression of Barrett's oesophagus by endoscopic argon beam plasma ablation.
    Morris CD, Byrne JP, Armstrong GR, Attwood SE.
    Br J Surg; 2001 Oct 15; 88(10):1357-62. PubMed ID: 11578292
    [Abstract] [Full Text] [Related]

  • 13. Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up.
    Ackroyd R, Kelty CJ, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW.
    Endoscopy; 2003 Jun 15; 35(6):496-501. PubMed ID: 12783347
    [Abstract] [Full Text] [Related]

  • 14. High power setting argon plasma coagulation for the eradication of Barrett's esophagus.
    Pereira-Lima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, Blaya C.
    Am J Gastroenterol; 2000 Jul 15; 95(7):1661-8. PubMed ID: 10925965
    [Abstract] [Full Text] [Related]

  • 15. Barrett's oesophagus--a pathologist's view.
    Fléjou JF, Svrcek M.
    Histopathology; 2007 Jan 15; 50(1):3-14. PubMed ID: 17204017
    [Abstract] [Full Text] [Related]

  • 16. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.
    Trautmann B, Wittekind C, Strobel D, Meixner H, Keymling J, Gossner L, Ell C, Hahn EG.
    Eur J Gastroenterol Hepatol; 1996 Aug 15; 8(8):799-804. PubMed ID: 8864678
    [Abstract] [Full Text] [Related]

  • 17. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C, Buoncristiano T, Furth EE, Falk GW, Ginsberg GG.
    Gastrointest Endosc; 2013 Feb 15; 77(2):190-9. PubMed ID: 23317687
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
    Schembre DB, Huang JL, Lin OS, Cantone N, Low DE.
    Gastrointest Endosc; 2008 Apr 15; 67(4):595-601. PubMed ID: 18279860
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.